| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/09/2003 | US20030009774 Trangenic rodent for use as model in evaluation of xenobiotics |
| 01/09/2003 | US20030009295 System and method for retrieving and using gene expression data from multiple sources |
| 01/09/2003 | US20030009292 System, method, and computer software for genotyping analysis and identification of allelic imbalance |
| 01/09/2003 | US20030009016 Can be use for genetic, diagnostic, and forensic applications such as for identity and paternity analysis, genetic mappling studies |
| 01/09/2003 | US20030008924 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008808 Retrovirus primes reverse transcription by inhibiting ribosomal binding/propagation of microbial tRNA |
| 01/09/2003 | US20030008807 Novel signaling pathway for the production of inflammatory pain and neuropathy |
| 01/09/2003 | US20030008414 Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and methods of use |
| 01/09/2003 | US20030008410 Immunoassay apparatus, kit and methods |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008364 Method and apparatus for separation of particles |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030008340 Metabolic biosensor and uses thereof |
| 01/09/2003 | US20030008339 Detection of preferential particles in sample; obtain reaction mixture, incubate with binding particles, detect complex, monitor and measure luminescence |
| 01/09/2003 | US20030008338 Assay methods and kits therefor |
| 01/09/2003 | US20030008337 Analytical system based upon spore germination |
| 01/09/2003 | US20030008331 Directed evolution biosensors |
| 01/09/2003 | US20030008319 Sequence based screening |
| 01/09/2003 | US20030008318 Determination of the number of copies of a preferential nucleotide sequence in sample; obtain sample, incubate with solid support and probe, detecting the amount of binding of the first and second labelled complementary |
| 01/09/2003 | US20030008317 Detection of modulator of translation; generate translation reaction mixture, incubate with modulator, detect polypeptide generation, generation of polypeptides indicates translation has not been inhibited |
| 01/09/2003 | US20030008316 Anthraquinone and its derivatives |
| 01/09/2003 | US20030008315 Ribozyme-encoding DNA and a composition containing an oligonucleotide substrate and a method for measuring transcription rates |
| 01/09/2003 | US20030008313 Process for enhanced molecular target detection using layered rolling circle amplification |
| 01/09/2003 | US20030008312 Provision of DNA investigating tools |
| 01/09/2003 | US20030008309 Microarray for use in the detection of preferential particles in sample; for use in the diagnosis of tumors |
| 01/09/2003 | US20030008308 Nucleic acid amplification utilizing microfluidic devices |
| 01/09/2003 | US20030008307 Methods for diagnosing activated protein C resistance associated with a factor V genetic mutation and compositions thereof |
| 01/09/2003 | US20030008306 Nucleotide sequence for use in the generation of preferential oligomers |
| 01/09/2003 | US20030008305 Oligonucleotide and method for detecting verotoxin |
| 01/09/2003 | US20030008304 Fluorescent quenching detection reagents and methods |
| 01/09/2003 | US20030008303 Probe designing method and information processing apparatus |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | US20030008301 Association between schizophrenia and a two-marker haplotype near PILB gene |
| 01/09/2003 | US20030008298 Primers-attached vector elongation (PAVE): a 5'-directed CDNA cloning strategy |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008296 Method for determining polymorphism |
| 01/09/2003 | US20030008294 Nucleotide sequences for use as tools in human therapeutics and diagnostics |
| 01/09/2003 | US20030008293 Detection of polymorphism in preferential nucleotide sequences; obtain cells, extract nucleotide sequences, incubate with probe, detect signal, monitor hybridization pattern |
| 01/09/2003 | US20030008292 Capturing sequences adjacent to type-IIs restriction sites for genomic library mapping |
| 01/09/2003 | US20030008290 Identification of a defined region of a transcript which corresponds to a region of an expressed gene |
| 01/09/2003 | US20030008289 Nucleotide sequences coding receptor proteins; for use in the treatment of pain, cardiovascular, and gastrointestinal disorders |
| 01/09/2003 | US20030008288 Detection and treatment of polycystic kidney disease |
| 01/09/2003 | US20030008285 Method of DNA sequencing using cleavable tags |
| 01/09/2003 | US20030008284 Polynucleotides related to colon cancer |
| 01/09/2003 | US20030008283 Method for screening for drug candidates for modulating transcription factor activity |
| 01/09/2003 | US20030008282 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2003 | US20030008281 Detection of preferential mutations in preferential genes; obtain tissue sample, incubate with primer, detect signal, presence of signal indicates mutation |
| 01/09/2003 | US20030008280 Detection of viral enzymatic activity in sample; obtain sample, incubate with substrate, monitor generation of reaction product, the presence of product indicates enzyme activity |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008278 Method of amplifying or detecting HIV-1 RNA |
| 01/09/2003 | US20030008276 Screens for susceptibility to immunodeficiency and viral disease |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
| 01/09/2003 | US20030008272 Detecting therapeutic agents in sample; obtain cell, expose to oxidatve stress, incubate with therapeutic agent, monitor response, reduced damage due to oxidative stress indicates preventive or therapeutic agent |
| 01/09/2003 | US20030007983 Two-hybrid assay that detects HIV-1 reverse transcriptase dimerization |
| 01/09/2003 | US20030007898 Separation, screening, analyzing; microchannel for fluid flow |
| 01/09/2003 | US20030007894 Measurement using light; optical gradient force |
| 01/09/2003 | US20030006608 Wearable folded map |
| 01/09/2003 | US20030006193 Using magnetically attractable particles; fast processing of a plurality of samples |
| 01/09/2003 | US20030006190 Modified microporous membrane for non-specific and sequence-specific nucleic acid capture and methods of use |
| 01/09/2003 | US20030006143 Directed assembly of functional heterostructures |
| 01/09/2003 | CA2779653A1 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | CA2491110A1 Synthesis and use of organosilica particles |
| 01/09/2003 | CA2486789A1 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | CA2452690A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | CA2452368A1 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | CA2452202A1 Diagnostic methods and agents |
| 01/09/2003 | CA2452200A1 Method for identifying compounds that specifically deplete mast cells |
| 01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | CA2452171A1 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 01/09/2003 | CA2452094A1 Screening method for identifying cancer therapy-relevant compounds |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2452029A1 A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases |
| 01/09/2003 | CA2451959A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | CA2451795A1 Cell-based high-throughput screening methods |
| 01/09/2003 | CA2451756A1 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | CA2451739A1 Hcv e1e2 vaccine compositions |
| 01/09/2003 | CA2451699A1 Compositions and methods for inhibiting platelet activation and thrombosis |
| 01/09/2003 | CA2451286A1 Method for kidney disease detection by protein profiling |
| 01/09/2003 | CA2451218A1 Diagnosis and treatment of cancer |
| 01/09/2003 | CA2451129A1 Glaucoma treatments with reduced hyperpigmentation |
| 01/09/2003 | CA2450985A1 Polymer stabilized proteinases |
| 01/09/2003 | CA2450725A1 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 01/09/2003 | CA2450353A1 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 01/09/2003 | CA2450126A1 Gene expression alterations underlying the retardation of aging by caloric restriction in mammals |
| 01/09/2003 | CA2449105A1 Novel technology for genetic mapping |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1273914A1 Hypotensors |
| 01/08/2003 | EP1273668A1 Nucleic acid primers of acid-fast bacterium and method of identifying acid-fast bacterium |
| 01/08/2003 | EP1273666A1 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 01/08/2003 | EP1273661A2 Heliothis virescens (tobacco budworm) 26/29 cysteine protease and uses thereof |
| 01/08/2003 | EP1272852A1 Tpst-assay for diagnosis of autism and related disorders |
| 01/08/2003 | EP1272851A1 Method and device for detecting molecules by means of impedance spectroscopy |